x
Filter:
Filters applied
- Oncology
- Shetty, Anup SRemove Shetty, Anup S filter
- Fowler, Kathryn JRemove Fowler, Kathryn J filter
Publication Date
Please choose a date range between 2016 and 2018.
Oncology
3 Results
- Oncology
Improved Detection of Clinically Significant Prostate Cancer With Software-assisted Systematic Biopsy Using MR/US Fusion in Patients With Negative Prostate MRI
UrologyVol. 120p162–166Published online: June 26, 2018- Yifan Meng
- Joel M. Vetter
- Alexander A. Parker
- Christopher T. Arett
- Gerald L. Andriole
- Anup S. Shetty
- and others
Cited in Scopus: 3To compare detection rates of clinically significant prostate cancer (Gleason 7 or above) between standard transrectal ultrasound guided biopsy (TRUSGB) and software-assisted systematic biopsy (SASB) using magnetic resonance/ultrasound fusion in the setting of negative multiparametric magnetic resonance imaging (mpMRI) in biopsy-naïve patients. - Oncology
Cognitive Versus Software Fusion for MRI-targeted Biopsy: Experience Before and After Implementation of Fusion
UrologyVol. 119p115–120Published online: June 22, 2018- Steven M. Monda
- Joel M. Vetter
- Gerald L. Andriole
- Kathryn J. Fowler
- Anup S. Shetty
- Jonathan R. Weese
- and others
Cited in Scopus: 25To compare the diagnostic performance of the 2 most common approaches of magnetic resonance imaging targeted biopsy (TB)—cognitive registration targeted biopsy (COG-TB) and software fusion targeted biopsy (FUS-TB)—we assessed our institutional experience with both methods. TB has emerged to complement systematic template biopsy (SB) in prostate cancer (PCa) diagnosis; however, which magnetic resonance imaging targeting methodology is diagnostically better remains unclear. - Oncology
Determination of the Role of Negative Magnetic Resonance Imaging of the Prostate in Clinical Practice: Is Biopsy Still Necessary?
UrologyVol. 102p190–197Published online: November 11, 2016- Robert S. Wang
- Eric H. Kim
- Joel M. Vetter
- Kathryn J. Fowler
- Anup S. Shetty
- Aaron J. Mintz
- and others
Cited in Scopus: 30To assess the negative predictive value (NPV) of multiparametric magnetic resonance imaging (mpMRI) for detection of prostate cancer (PCa) in routine clinical practice and to identify characteristics of patients for whom mpMRI fails to detect high-grade (Gleason score ≥7) disease.
